quinuclidines has been researched along with Aging in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (36.36) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 2 (9.09) | 29.6817 |
| 2010's | 6 (27.27) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Beck, WD; Blake, DT; Callahan, PM; Plagenhoef, MR; Terry, AV | 1 |
| Antier, D; Buron, F; Chalon, S; Damont, A; Dollé, F; Doméné, A; Emond, P; Foucault-Fruchard, L; Page, G; Rodrigues, N; Routier, S; Windsor, M | 1 |
| Akashi, K; Kadoyama, K; Kamezaki, K; Kato, K; Miyamoto, T; Mori, Y; Nakamura, T; Shiratsuchi, M; Takenaka, K; Uchida, M | 1 |
| Compion, G; Dale, M; Stow, B; Tretter, R; Wagg, A | 2 |
| Wein, AJ | 1 |
| Cornu, JN | 1 |
| Borsini, F; Buccafusco, JJ; Leusch, A; Terry, AV | 1 |
| Iida, H; Inoue, N; Ishida, H; Ishikawa, Y; Yuan, Z | 1 |
| Burgoyne, RD; Gross, J; Rose, SP | 1 |
| Gade, J; Tollefson, GD | 1 |
| Morin, AM; Wasterlain, CG | 1 |
| Brookes, N; Burt, DR | 1 |
| Ohyama, M; Ozawa, Y; Suzuki, M; Yamaguchi, T; Yamamoto, M | 1 |
| Iwai, A; Ozawa, Y; Suzuki, M; Yamaguchi, T; Yamamoto, M | 1 |
| Flügel, C; Kaufman, PL; Poyer, JF | 1 |
| Crawford, KC; Fisher, A; Fitten, LJ; Halgren, E; O'Neill, J; Refai, D; Siembieda, DW | 1 |
| Daniels, MP; Nirenberg, M; Sugiyama, H | 1 |
| Abood, LG; Aronstam, RS; Kellogg, C | 1 |
| Brandeis, R; Dachir, S; Fisher, A; Levy, A; Sapir, M | 1 |
| Kitamura, Y; Nomura, Y; Ohnuki, T; Zhao, XH | 1 |
| Bering, B; Müller, WE | 1 |
1 trial(s) available for quinuclidines and Aging
| Article | Year |
|---|---|
Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Analysis of Variance; Attention; Cognition; Cognitive Dysfunction; Cross-Over Studies; Double-Blind Method; Female; Humans; Least-Squares Analysis; Male; Mandelic Acids; Memory; Muscarinic Antagonists; Quinuclidines; Risk Factors; Solifenacin Succinate; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; United Kingdom; Urinary Bladder, Overactive; Urological Agents | 2013 |
21 other study(ies) available for quinuclidines and Aging
| Article | Year |
|---|---|
Aged rhesus monkeys: Cognitive performance categorizations and preclinical drug testing.
Topics: Aging; Animals; Cognition; Cognitive Dysfunction; Drug Evaluation, Preclinical; Female; Macaca mulatta; Male; Memory, Short-Term; Nootropic Agents; Quinuclidines; Thiophenes | 2021 |
Neuroprotective effect of the alpha 7 nicotinic receptor agonist PHA 543613 in an in vivo excitotoxic adult rat model.
Topics: Aging; alpha7 Nicotinic Acetylcholine Receptor; Animals; Bridged Bicyclo Compounds, Heterocyclic; Isoquinolines; Male; Neurons; Neuroprotective Agents; Nicotinic Agonists; Quinuclidines; Rats, Wistar; Signal-To-Noise Ratio | 2017 |
Comparison between Antiemetic Effects of Palonosetron and Granisetron on Chemotherapy-Induced Nausea and Vomiting in Japanese Patients Treated with R-CHOP.
Topics: Adult; Aged; Aging; Antibodies, Monoclonal, Murine-Derived; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Asian People; Cyclophosphamide; Doxorubicin; Female; Granisetron; Humans; Isoquinolines; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Palonosetron; Prednisone; Quinuclidines; Risk Factors; Rituximab; Sex Characteristics; Treatment Outcome; Vincristine; Vomiting; Young Adult | 2017 |
Reply from authors re: Jean-Nicolas Cornu. Overactive bladder medical management in the elderly: it is time to go beyond the tip of the iceberg. Eur Urol 2013;64:82-3.
Topics: Aging; Cognition; Cognitive Dysfunction; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urological Agents | 2013 |
Re: randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study.
Topics: Aging; Cognition; Cognitive Dysfunction; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Quinuclidines; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urological Agents | 2014 |
Overactive bladder medical management in the elderly: it is time to go beyond the tip of the iceberg.
Topics: Aging; Cognition; Cognitive Dysfunction; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urological Agents | 2013 |
Memory-related task performance by aged rhesus monkeys administered the muscarinic M(1)-preferring agonist, talsaclidine.
Topics: Aging; Animals; Dose-Response Relationship, Drug; Female; Macaca mulatta; Male; Memory; Muscarinic Agonists; Psychomotor Performance; Quinuclidines; Receptor, Muscarinic M1; Receptors, Muscarinic; Time Factors | 2002 |
Age-related decreases in the response of aquaporin-5 to acetylcholine in rat parotid glands.
Topics: Acetylcholine; Adrenergic Agonists; Aging; Animals; Aquaporin 5; Aquaporins; Cell Membrane; Cholinergic Agents; Epinephrine; GTP-Binding Protein alpha Subunits, Gq-G11; Heterotrimeric GTP-Binding Proteins; Male; Membrane Proteins; Muscarinic Agonists; Nitric Oxide Synthase; Parotid Gland; Quinuclidines; Rats; Rats, Wistar; Receptor, Muscarinic M3; Receptors, Muscarinic; Thiophenes | 2003 |
Influence of prenatal hypoxia on brain development: effects on body weight, brain weight, DNA, protein, acetylcholinesterase, 3-quinuclidinyl benzilate binding, and in vivo incorporation of [14C]lysine into subcellular fractions.
Topics: Acetylcholinesterase; Aging; Animals; Body Weight; Brain; DNA; Female; Fetal Diseases; Fetus; Hypoxia; Lysine; Nerve Tissue Proteins; Organ Size; Pregnancy; Quinuclidines; Quinuclidinyl Benzilate; Rats; Subcellular Fractions | 1981 |
A comparison of human muscarinic cholinergic receptor properties subsequent to alcohol abuse and senescence.
Topics: Aging; Alcoholism; Hippocampus; Humans; Kinetics; Middle Aged; Quinuclidines; Quinuclidinyl Benzilate; Receptors, Cholinergic; Receptors, Muscarinic | 1983 |
Aging and rat brain muscarinic receptors as measured by quinuclidinyl benzilate binding.
Topics: Acetylcholinesterase; Aging; Animals; Brain; Cell Nucleus; Cerebellum; Choline O-Acetyltransferase; Corpus Striatum; Female; Quinuclidines; Quinuclidinyl Benzilate; Rats; Receptors, Cholinergic; Receptors, Muscarinic; Synaptosomes | 1980 |
Development of muscarinic receptor binding in spinal cord cell cultures and its reduction by glutamic and kainic acids.
Topics: Aging; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Glutamates; Kainic Acid; Mice; Mice, Inbred Strains; Pyrrolidines; Quinuclidines; Quinuclidinyl Benzilate; Receptors, Cholinergic; Receptors, Muscarinic; Spinal Cord | 1980 |
Effects of (-)-S-2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4,5]decane L-tartrate monohydrate (YM796), a novel muscarinic agonist, on disturbance of passive avoidance learning behavior in drug-treated and senescence-accelerated mice.
Topics: Aging; Amnesia; Animals; Avoidance Learning; Cholinesterase Inhibitors; Cycloheximide; Hemicholinium 3; Mice; Mice, Mutant Strains; Muscarinic Agonists; Protein Synthesis Inhibitors; Quinuclidines; Scopolamine; Spiro Compounds; Thiophenes | 1995 |
Effect of YM796, a novel muscarinic agonist, on the impairment of passive avoidance response in senescence-accelerated mice.
Topics: Aging; Aminoquinolines; Amitriptyline; Animals; Avoidance Learning; Cholinesterase Inhibitors; Mice; Mice, Inbred Strains; Muscarinic Agonists; Psychotropic Drugs; Quinuclidines; Spiro Compounds; Thiophenes | 1995 |
Age does not affect contractile responses of the isolated rhesus monkey ciliary muscle to muscarinic agonists.
Topics: Aging; Animals; Atropine; Carbachol; Cells, Cultured; Ciliary Body; Culture Media; Ganglionic Stimulants; Macaca mulatta; Muscle Contraction; Muscles; Quinuclidines | 1993 |
Divided attention-enhancing effects of AF102B and THA in aging monkeys.
Topics: Aging; Animals; Attention; Cholinergic Agents; Cholinesterase Inhibitors; Female; Macaca radiata; Male; Muscarinic Agonists; Psychomotor Performance; Quinuclidines; Tacrine; Thiophenes | 1999 |
Muscarinic acetylcholine receptors of the developing retina.
Topics: Aging; Animals; Binding, Competitive; Chick Embryo; Kinetics; Parasympatholytics; Parasympathomimetics; Quinuclidines; Receptors, Cholinergic; Receptors, Muscarinic; Retina | 1977 |
Development of muscarinic cholinergic receptors in inbred strains of mice: identification of receptor heterogeneity and relation to audiogenic seizure susceptibility.
Topics: Acoustic Stimulation; Aging; Animals; Animals, Newborn; Brain; Brain Stem; Carbachol; Cerebral Cortex; Corpus Striatum; Hypothalamus; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Quinuclidines; Receptors, Cholinergic; Receptors, Muscarinic; Seizures; Thalamus | 1979 |
Reversal of age-related cognitive impairments by an M1 cholinergic agonist, AF102B.
Topics: Aging; Animals; Learning; Male; Memory; Parasympathomimetics; Quinuclidines; Rats; Rats, Inbred Strains; Thiophenes | 1990 |
Ligand-binding characteristics of [3H]QNB, [3H]prazosin, [3H]rauwolscine, [3H]TCP and [3H]nitrendipine to cerebral cortical and hippocampal membranes of senescence accelerated mouse.
Topics: Aging; Animals; Cerebral Cortex; Hippocampus; Male; Mice; Prazosin; Quinuclidines; Quinuclidinyl Benzilate; Receptors, Adrenergic, alpha; Receptors, Muscarinic; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter | 1989 |
Stereospecific 3H-QNB binding to human erythrocyte membranes associated with muscarinic cholinergic receptors.
Topics: Adult; Aging; Animals; Atropine; Brain; Carbachol; Erythrocyte Membrane; Female; Guanylyl Imidodiphosphate; Humans; In Vitro Techniques; Male; Middle Aged; Myocardium; Oxotremorine; Quinuclidines; Quinuclidinyl Benzilate; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Stereoisomerism | 1987 |